Merck & Company to transform drug developments with Smart Inventory Management and Customer Intelligence
Key Insights and Signals – Hospital & Healthcare
Centre Setup and Expansion AdventHealth opens a new clinic for long-haul COVID treatment The new clinic will help people who still have COVID-19 symptoms three months after the virus left their bodies. Dr. Dwyane Gordon oversees this new clinic. Read More>> Willis-Knighton opens WK Northwood Medical Plaza in Blanchard The medical plaza is the latest in a new healthcare model by Willis-Knighton that combines WK Quick Care with WK Physician Network clinics and diagnostic X-ray services. Read More>>Layoff Guardant Health lays off 130 employees, or 7 percent of its workforce Departments including Account management, Bioinformatics, and Technology Development were affected by the layoffs and restructuring. Read More>>Merger and Acquisition AlerisLife Chairman to buy company via ABP Acquisition for USD 43.8 Mn ABP would pay USD 1.31 per share to acquire AlerisLife, marking an 85% premium to the average trading price over the past 30 trading days. Read More>>Deal Agilent and Quest Diagnostics to collaborate on Lung Cancer Diagnostics The two companies inked the deal to expand access to the Agilent Resolution ctDx FIRST liquid biopsy sequencing test. The ctDx FIRST is targeted at non-small lung cancer patients. Read More>>Executive Movements PacificSource Health Plans names President and CEO Dr. John Espinola will replace retiring Ken Provencher on April 3. Espinola comes from Blue Cross, where he served as Executive VP and Chief Strategy and Product Officer. Read More>> Bryan T. Kelly to succeed Shapiro as CEO of Hospital for Special Surgery Kelly will succeed President and CEO Louis A. Shapiro in a phased-in handover in 2023. Kelly joined HSS in 1996 and is a world-renowned surgeon, scientist, and educator specializing in sports medicine. Read More>> St. Jude Children’s names first Chief Business Innovation Officer In this new role, Ms. Corbin will manage the Office of Strategic Innovation and Design, allocating its USD 3 Bn to construction projects. Ms. Corbin has served as Partner & Director at IDEO’s Chicago Studio. Read More>>Financial and Market Activity Parkview Health reports net losses ahead of UCHealth merger The Health system has agreed to merge with UCHealth and reported a net operating loss of USD 11.2 Mn for six months. Investment values gave a boost in the most recent six-month period to help mitigate overall losses. Read More>> Dr Lal PathLabs Q3 Results: Net profit drops 8% to USD 6.5 Mn Revenues declined 1.5% to USD 59 Mn in Q3FY23 from USD 60.8 Mn in Q3FY2022. Non-Covid revenues climbed 9.1% to USD 57 Mn, while Covid testing revenues fell 80.4% to USD 1.3 Mn. Read More>>
Key Insights and Signals in Medical Devices
Product Launch Axion Biosystems launched a new live-cell imaging platform, Omni Pro 12 The platform features integrated robotics and a multi-plate design compatible with any incubator. It offers enhanced flexibility to scientists and drug developers conducting live-cell imaging experiments. Read More>> Bio-Techne releases new RNAscope Plus smRNA-RNA Detection Assay The device allows single-cell and sub-cellular fluorescence detection of a small regulatory RNA with chosen RNAs or biomarkers in the same tissue area. Read More>> Qiagen Digital Insights launches NGS analysis to process whole genome The upgraded product processes the whole genome in 25 minutes for $1 in cloud computing costs. Qiagen CLC Genomics Workbench Premium software speeds up the whole genome, whole exome, and large panel sequencing data processing and interpretation. Read More>>Deals Manipal Hospitals ties up with Fujifilm for storing sensitive medical documents Under the long-term agreement, the hospital would be provided with a large-scale Picture Archiving and Communication System (PACS) powered by FUJIFILM India. Read More>> European Radiosurgery Center Munich invests in second Accuray CyberKnife System The next-gen CyberKnife S7 System will enable their team to treat the high volume of patients who would benefit from extremely precise radiation treatments. Read More>>Executive Movement ResMed appoints Michael Farrell as Chair of its Board The company’s board of directors has appointed CEO Michael Farrell as chair of the board. Mr. Farrell succeeds the current chair Peter Farrell who will become chair emeritus and remain an active board member. Read More>>Financial and Market Activity Bio-Techne Fiscal Q2 Revenues Inch up as Protein business lags but Genomics boom In Q2, the firm reported Diagnostics and Genomics revenues of USD 68 Mn, up 5 percent YoY from USD 64.5 Mn. The company reported USD 203.9 Mn in revenues for the Protein Business, down 1 percent from USD 205.0 Mn in the prior-year quarter. Read More>> Siemens Healthineers Q1 Dx revenues fall 21 Percent The company’s diagnostics revenues fell 21 percent in the first fiscal quarter on softer demand for rapid COVID-19 antigen tests, although its overall revenues remained flat year to year. Read More>>
Key Insights and Signals in Pharmaceutical
Partnership AstraZeneca, Capitainer to develop biomarker protocols using at-home patient sampling device The research collaboration with AstraZeneca R&D aims to develop protocols for biomarkers relevant to AstraZeneca’s clinical drug programs using Capitainer’s self-sampling product. Read More>>Mass Hiring Moderna to add approximately 2,000 jobs in Greater Boston The company employs over 3,900 people globally. The company plans to add over 2,000 new regional employees this year. Read More>>Executive Movement CureVac Welcomes Myriam Mendila as New Chief Development Officer Myriam’s expertise in product development in the pharmaceutical industry, particularly in oncology, will be a significant asset to CureVac to advance their mRNA product pipeline. Read More>>Product Launch Hikma launched naloxone hydrochloride injection The drug is used for the emergency treatment of a known or suspected opioid overdose and is the third PFS product launched by Hikma. The launch of this product expands Hikma’s portfolio of addiction therapy treatments. Read More>>Financial and Market Activity Alembic Pharma Q3 PAT slips 29% YoY The company reported a 29% drop in consolidated net profit to USD 14.6 Mn despite an 18.7% rise in net sales to USD 180 Mn in Q3 FY23 over Q3 FY22. PBT declined 23.05% YoY to USD 18 Mn in the quarter ended 31 December 2022. Read More>> Bulgaria’s Sopharma grows non-cons net profit by 66% in 2022 The company’s standalone net profit soared to USD 21 Mn in 2022 from USD 13 Mn the year prior. Exports to European countries grew by an annual 16.3% to USD 64 Mn as sales in Russia and Ukraine increased, by 11% and 20%, respectively. Read More>> Laurus Labs posts a 32% profit jump on demand for drug ingredients The company reported a 32.1% rise in third-quarter profit supported by strong demand for chemicals and other ingredients used in medicines. Read More>>
Did you find the newsletter helpful? *|SURVEY: Yes|* *|SURVEY: No|*
Latest Industry Insights from Draup Braindesk
Medical Devices:
Abbott Laboratories wants to develop a neuromodulation device that wirelessly charges and has the lowest recharge load compared to competing rechargeable SCS systems.
Abbott Laboratories improves chronic pain patient charging and develops SCS therapy to enable future advancements without changing the implant.
Abbott Laboratories’ Talisman system, based on the Amplatzer PFO Occluder, simplifies physician usage and reduces preparation time.
Abbott Laboratories is developing a new aspiration system to break up and remove peripheral vascular clots.
Nutritional Products:
Abbott Laboratories’ AI-enabled nutritional mobile app helps diabetic patients follow their doctors’ advice on food, medication, and other health concerns.
Abbott Laboratories strives to use a 3D Printing platform to develop prototype tools that enhance nutritional product development for devices used to treat vascular disease.
Abbott Laboratories wants to create FreeStyle Libre sensor-based technology to illustrate the effect of dietary choices on health.
Service Opportunities:
Greater Chicago Area, United States, serves as the hub focusing on System Integration, Business Intelligence & Analytics, and IT Consulting related engagements.
Product Engineering Services is the highly outsourced segment and holds approximately 36% of the total outsourcing headcount. IBM and Cognizant are the key strategic partners for Abbott Laboratories.
Key Funding Alert
VitaDAO raises USD 4.1 Mn featuring Pfizer
VitaDAO’s first biotech firm, whose announcement is expected in March 2023, will be built using part of this funding. This will be the first such involvement by a DAO in the science research and medical fields. Read More>>
Startup Spotlight
Company – Enable Dental Total Funding– USD 16.34 Mn About: Enable Dental’s mission is to expand access to dental care for in-need populations. The company leverages technology to tailor patient experiences, improve results, and minimize delivery costs. Read More>>
Latest Reports Published in Draup
Merck & Company Account Intelligence Report
Merck focuses on developing their supply chain, drug developments, and manufacturing operations through smart inventory management and customer intelligence. Read More>>
Here’s what’s new on our Sales Intelligence Platform Introducing Account Priorities View in Business Intentions
Identify account priorities quickly with the refreshed new view of Business Intentions.
We use cookies to provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!
